nipradilol has been researched along with glutamic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, A; Katsuki, H; Kume, T; Shirakawa, H; Taguchi, R; Yamaguchi, T | 1 |
| Agarwal, N; Kanamori, A; Nagai-Kusuhara, A; Nakamura, M; Nakanishi, Y; Negi, A; Tatsumi, Y | 1 |
2 other study(ies) available for nipradilol and glutamic acid
| Article | Year |
|---|---|
Nitric oxide-mediated effect of nipradilol, an alpha- and beta-adrenergic blocker, on glutamate neurotoxicity in rat cortical cultures.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Calcium; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fetus; Glutamic Acid; Glutathione; Lactoylglutathione Lyase; Neurons; Neuroprotective Agents; Nitric Oxide; Pregnancy; Propanolamines; Rats; Rats, Wistar | 2006 |
Nipradilol protects rat retinal ganglion cells from apoptosis induced by serum deprivation in vitro and by diabetes in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Calcium; Caspase 3; Cell Line; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Glutamic Acid; In Situ Nick-End Labeling; Male; Propanolamines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Serum; Vasodilator Agents | 2008 |